Kinase inhibitors for the treatment of disease
US7531665B2 · kind B2 · utility
0Cited by
12References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 20, 2004 |
| Grant date | May 12, 2009 |
| Priority date | — |
| Expiry date | Feb 19, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.